Does ALEMTUZUMAB Cause Hypersensitivity? 151 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 151 reports of Hypersensitivity have been filed in association with ALEMTUZUMAB (Campath). This represents 1.1% of all adverse event reports for ALEMTUZUMAB.
151
Reports of Hypersensitivity with ALEMTUZUMAB
1.1%
of all ALEMTUZUMAB reports
4
Deaths
76
Hospitalizations
How Dangerous Is Hypersensitivity From ALEMTUZUMAB?
Of the 151 reports, 4 (2.6%) resulted in death, 76 (50.3%) required hospitalization, and 7 (4.6%) were considered life-threatening.
Is Hypersensitivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 151 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Hypersensitivity?
ETANERCEPT (10,846)
ADALIMUMAB (10,641)
METHOTREXATE (9,799)
TOCILIZUMAB (9,076)
ABATACEPT (8,945)
INFLIXIMAB (8,519)
RITUXIMAB (8,408)
ADAPALENE (8,356)
LEFLUNOMIDE (7,926)
CERTOLIZUMAB PEGOL (7,353)
Which ALEMTUZUMAB Alternatives Have Lower Hypersensitivity Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET